Clinical Pharmacokinetics of Paraaminosalicylic Acid Tablets

QR Code

Clinical Pharmacokinetics of Paraaminosalicylic Acid Tablets

Pharmacokinetic parameters of PAS-Akri coated tablets (Akrikhin, Russia) were investigated. The tablets contain paraaminosalicylic acid (PAS) as sodium dihydrate in an amount of 1000 mg. The single oral dose of the drug for healthy volunteers in the trial was 6, 9 or 12 tablets. In 7 days the dosage...

Full description

Saved in:

Bibliographic Details
Main Authors:	I. I. Miroshnichenko, G. B. Sokolova, L. V. Mokhireva
Format:	Article
Language:	Russian
Published:	LLC "Publishing House OKI" 2020-05-01
Series:	Антибиотики и Химиотерапия
Subjects:	clinical pharmacokinetics antituberculosis drugs paraaminosalicylic acid volunteers
Online Access:	https://www.antibiotics-chemotherapy.ru/jour/article/view/200
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Pharmacokinetics and Safety with Bioequivalence of Isosorbide Mononitrate Sustained-Release Tablets in Chinese Healthy Volunteers: Bioequivalence Study
by: Wu B, et al.
Published: (2025-07-01)

Assessment of the influence of demographic and anthropometric indicators on the variability of pharmacokinetic parameters
by: V. B. Vasilyuk, et al.
Published: (2024-06-01)

A comparative study of pharmacokinetics of coated tablets of mycophenolic acid
by: A. L. Khokhlov, et al.
Published: (2016-11-01)

COMPARATIVE PHARMACOKINETICS AND EFFECT ON THE HEMODYNAMICS OF ORIGINAL AND GENERIC NEBIVOLOL IN HEALTHY VOLUNTEERS
by: E. I. Bambysheva, et al.
Published: (2016-05-01)

Levofloxacin (Tavanic) in Complex Therapy of Tuberculosis
by: G. B. Sokolova, et al.
Published: (2020-05-01)

Pharmacokinetics of Pentanedioic Acid Imidazolyl Ethanamide in Healthy Volunteers
by: I. G. Gordeev, et al.
Published: (2021-05-01)

ANTITUBERCULOSIS DRUG DOSAGE FORMS: RANGE, KEY BENEFITS AND PROSPECTS OF TECHNOLOGICAL IMPROVEMENT
by: M. E. Kim, et al.
Published: (2016-09-01)

The Study of Pharmacokinetics Parameters of Morphine Hydrochloride, Long-acting Tablets in Cancer Patients with Severe Chronic Pain Syndrome
by: E. A. Ezhova, et al.
Published: (2020-05-01)

Organizing of pharmacokinetic investigations
by: I. I. Miroshnichenko, et al.
Published: (2022-02-01)

Results of a phase I open randomized comparative crossover clinical trial to assess the safety and pharmacokinetics of Glurazyme® (imiglucerase) in comparison with the reference product in healthy volunteers
by: S. B. Fitilev, et al.
Published: (2019-12-01)

Pharmacokinetic Interactions of Phenosanic Acid with Valproic Acid and Carbamazepine in Dogs
by: M. V. Karlina, et al.
Published: (2022-12-01)

Ferulic Acid as an Anti-Inflammatory Agent: Insights into Molecular Mechanisms, Pharmacokinetics and Applications
by: Jiaying Liu, et al.
Published: (2025-06-01)

Analysis of Pharmacokinetic Parameters of Acetylsalicylic Acid for Prediction of Potential Nephrotoxic Effects
by: L. M. Krasnykh, et al.
Published: (2021-12-01)

Study of the effect of food on the bioavailability, safety and tolerability of Aterixen<sup>®</sup> 100 mg tablet in healthy volunteers
by: V. B. Vasilyuk, et al.
Published: (2023-07-01)

ESTIMATION OF CLINICAL AND PHARMACOKINETIC EQUIVALENCE OF ORIGINAL AND GENERIC CARVEDILOLS IN PATIENTS WITH HYPERTENSION OF 1-2 GRADES
by: E. I. Bambysheva, et al.
Published: (2016-01-01)

Comparative Study of Hepatoprotective Action of Remaxol, Reamberin and Ademethionine in Liver Injury Induced by Antituberculosis Drugs (Experimental Study)
by: D. S. Sukhanov, et al.
Published: (2020-05-01)

Prospects of Pharmacogenetic Testing for Design of Algorithms for Personalized Treatment of Tuberculosis of Respiratory Organs in the Astrakhan Region
by: B. I. Kantemirova, et al.
Published: (2020-05-01)

Experimental Simulation of the Liver Drug Injury for Investigation of New Hepatoprotectors
by: G. N. Mozhokina, et al.
Published: (2020-05-01)

Pharmacokinetic relationships in psychotropic drugs effects
by: G. B. Kolyvanov, et al.
Published: (2021-06-01)

PECULIARITIES OF BIOLOGICAL FEATURES OF MYCOBACTERIUM TUBERCULOSIS ON THE TERRITORY OF IRKUTSK REGION
by: O. A. Vorobiova, et al.
Published: (2012-09-01)

Hepatotropic Therapy in Treatment of Liver Injury
by: D. S. Sukhanov, et al.
Published: (2020-05-01)

Comparative Efficacy of Clinical Use of Reamberin, Remaxol and Ademethionine in Patients with Tuberculosis of the Respiratory Organs and Liver Drug-Injury
by: D. S. Sukhanov, et al.
Published: (2020-05-01)

PRIMARY MULTIDRUG RESISTANCE OF TUBERCULOSIS MYCOBACTERIUM ACCORDING TO DATA OF KRASNOYARSK REGIONAL TUBERCULOSIS DISPENSARY № 1 IN-PATIENT DEPARTMENT
by: N. M. Koretskaya, et al.
Published: (2012-09-01)

Study of the pharmacokinetics of moxidectin in the body of carnivores using an antiparasitic drug in the form of tablets
by: G. B. Arisova
Published: (2021-06-01)

Study of the pharmacokinetic profile of the medicinal product Gidazepam®, tablets, 50 mg in a bioequivalence study
by: E. V. Baskakov, et al.
Published: (2023-11-01)

Phase I pharmacokinetic study of etmaben, a malonic acid derivative
by: P. K. Karnakova, et al.
Published: (2024-11-01)

Pharmacokinetics and Safety of Oxycodone/Naloxone Prolonged-Release Tablets in Chinese Patients with Chronic Pain
by: He Y, et al.
Published: (2025-06-01)

Clinical pharmacokinetics of potassium competitive acid blockers: a systematic review and meta-analysis
by: Jiaqi Liu, et al.
Published: (2025-07-01)

Analysis of sparse data in pharmacokinetic studies
by: I. I. Miroshnichenko, et al.
Published: (2020-12-01)

Drug Transporters and Metabolizing Enzymes in Antimicrobial Drug Pharmacokinetics: Mechanisms, Drug–Drug Interactions, and Clinical Implications
by: Kaili Lin, et al.
Published: (2025-06-01)

Antituberculosis Properties of Methyldioxotetrahydropyrimidine Sulfonisonicotinoyl Hydrazide
by: B. S. Kibrik, et al.
Published: (2020-05-01)

The Effect of Drug&ndash;Drug Interactions on the Pharmacokinetics of Isavuconazole: A Comprehensive Review
by: Sang Y, et al.
Published: (2025-06-01)

Population Pharmacokinetics of Tranexamic Acid in Chinese Population Undergoing Cardiac Surgery with Cardiopulmonary Bypass
by: Liu Y, et al.
Published: (2025-05-01)

Pharmacokinetic analysis of meropenem therapeutic drug monitoring data (TDM) in critically ill adult patients
by: I. B. Bondareva, et al.
Published: (2022-03-01)

Drug-Likeness, Pharmacokinetics, and Toxicity Prediction of Phytotoxic Terpenoids
by: Obinna Kenneth Didigwu, et al.
Published: (2024-04-01)

Pharmacokinetic Studies of Radiopharmaceuticals
by: A. S. Lunev, et al.
Published: (2022-12-01)

Pharmacokinetics of a potential antiepileptic drug GIZh-298
by: G. B. Kolyvanov, et al.
Published: (2024-08-01)

Food–Drug Interactions: Effect of Propolis on the Pharmacokinetics of Enrofloxacin and Its Active Metabolite Ciprofloxacin in Rabbits
by: Ali Sorucu, et al.
Published: (2025-06-01)

Automated protocol templates with efficient schedule of activities table generation for healthy volunteer trials
by: Kyongeun Shin, et al.
Published: (2025-08-01)

Immunomodulator Intensification of Etioropic Therapy in Patients with Advanced Pulmonary Tuberculosis
by: V. M. Kolomiets, et al.
Published: (2020-05-01)